Results 121 to 130 of about 25,513 (245)

Dydrogesterone versus micronized vaginal progesterone for luteal phase support in artificial cycle frozen embryo transfer (REMODEL): a pilot prospective randomized controlled trial. [PDF]

Front Endocrinol (Lausanne)
Roelens C, Mackens S, Drakopoulos P, Van Landuyt L, De Vos M, Tournaye H, Blockeel C.   +6 more
europepmc   +1 more source

The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review. [PDF]

Cureus, 2023
Muneeba S, Acharya N, Mohammad S.
europepmc   +1 more source

Fertility outcomes and ovarian function recovery after anti‐NMDAR encephalitis: A retrospective cohort study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 9, Page 1823-1832, September 2026.
Acute hypothalamic–pituitary–ovarian axis suppression is common in anti‐NMDAR encephalitis, yet ovarian function and fertility recover favorably even in teratoma‐associated cases, supporting reassuring long‐term reproductive prognoses. Abstract Introduction Anti‐N‐methyl‐D‐aspartate receptor (anti‐NMDAR) encephalitis predominantly affects women of ...
Jia Wang, Jie Ding, Han Cai, YingXiang Wang, HaoTian Wu   +4 more
wiley   +1 more source

Effect of a luteal phase rescue protocol on live birth rates in frozen embryo transfer cycles. [PDF]

Front Reprod Health
Yazbeck C, Olivennes F, Kazdar N, Pietin-Vialle C, Gricourt S.   +4 more
europepmc   +1 more source

Comparison of Functional Vestibulo-Ocular Reflex in Follicular and Luteal Phase in Young Girls. [PDF]

J Int Adv Otol, 2023
Cengiz DU, Çolak SC, Koca HÜ.
europepmc   +1 more source

Injectable Bone Cements: A Generational Framework for Bioactivity, Porosity, and Mechanobiological Design at the Nanoscale

Advanced NanoBiomed Research, Volume 6, Issue 8, August 2026.
Key demographic, biological, and material considerations that drive the need for advanced injectable bone cement technologies. Injectable bone cements (IBCs) are widely used in orthopaedic and craniofacial applications due to their minimally invasive delivery and ability to provide early mechanical stabilisation.
Frank Fei, Yogambha Ramaswamy, Young Jung No   +2 more
wiley   +1 more source

Sex Hormone Levels and Pain Thresholds in the Luteal Phase of Healthy Women. [PDF]

Int J Womens Health
Zhang L, Sun M, Ding W, Zhao N, Zhang W.
europepmc   +1 more source

Tailored progesterone for luteal phase support: the way to go. [PDF]

JBRA Assist Reprod, 2023
Patel G, Vatsa R, Kashyap A.
europepmc   +1 more source

PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4+ lymphocytes

British Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2949-2959, August 2026.
Background Female sex hormones used in feminizing hormone therapy (FHT) may influence activation and persistence of HIV pre‐exposure prophylaxis (PrEP) medications. The clinical relevance of this interaction remains unclear, particularly for transgender and cisgender women (TGW and CGW).
Elizabeth Hastie, Megha Srivasta, Edward R. Cachay, Leah Burke, Sara Gianella, Stephen Rawlings, Frank Z. Stanczyk, Craig Sykes, Angela D. M. Kashuba, Jill Blumenthal, Mackenzie L. Cottrell   +10 more
wiley   +1 more source

Luteal phase oral dexamethasone administration alters endometrial steroid milieu. [PDF]

Endocr Connect
Homer NZM, Nicol M, Madhra M, Naredo-Gonzalez G, Laforest S, Slayden OD, Hillier SG, Walker BR, Warner P, Andrew R, Critchley HOD.   +10 more
europepmc   +1 more source